Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
  1. 4 Shares withheld for taxes Chief Medical Officer gave up 49,950 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Business Officer gave up 381 shares (to pay taxes)
  3. 4 Grant or award Chief Commercial Officer acquired 85,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Shares withheld for taxes Chief Business Officer gave up 381 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Business Officer gave up 381 shares (to pay taxes)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 84,000 shares at $4.71 ($395,900)
  9. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 10,000 shares at $4.71 ($47,131)
  10. 4 Open-market sale Director sold 93,843 shares at $4.71 ($442,291)
  11. 4 Grant or award Chief Medical Officer acquired 150,000 shares (grant or award)
  12. 4 Grant or award Director acquired 22,500 shares (grant or award)
  13. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 30,438 shares (to pay taxes)
  14. 4 Grant or award Chief Operating Officer acquired 160,000 shares (grant or award)
  15. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 109,680 shares (to pay taxes)
  16. 4 Grant or award Director acquired 22,500 shares (grant or award)
  17. 4 Grant or award Director acquired 22,500 shares (grant or award)
  18. 4 Grant or award Director acquired 22,500 shares (grant or award)
  19. 4 Grant or award Director acquired 22,500 shares (grant or award)
  20. 4 Grant or award Director acquired 22,500 shares (grant or award)

Page 3 of 22 · 436 filings